Both in Pharmaceuticals
Gain Therapeutics vs Biomea Fusion
Over the past year GANX returned −38.6% and BMEA returned −50.0%; their daily moves had a correlation of 0.21.
GANX −38.6% BMEA −50.0%Growth of $1, one year, split-adjusted
| Metric | GANX | BMEA |
|---|---|---|
| Price | $1.13 | $0.6599 |
| Market cap | $49.3M | $47.8M |
| Today | 0.00% | +3.19% |
| 1 month | −33.9% | −48.0% |
| 6 months | −40.5% | −55.4% |
| Year to date | −64.9% | −46.8% |
| 1 year | −35.8% | −50.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $12.7M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 64.1% | 121.8% |
| Short % of float | 7.6% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).